Literature DB >> 8249283

Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.

C H Herrmann1, A P Rice.   

Abstract

The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) Tat proteins are related transcriptional activators whose effects are likely to be mediated by a cellular factor. Using an in vitro kinase assay, we have shown that the Tat protein of HIV-2 and the activation domain of the Tat protein of HIV-1 specifically bind to a cellular protein kinase. Mutations in Tat that abolish transactivation activity in vivo abrogate the ability of the mutants to bind to the kinase in vitro. This is the first demonstration of a cellular factor that binds to Tat that is specific for a functional activation domain of Tat and that displays a biochemical activity. Additionally, we show that the Tat protein of HIV-2 serves as a substrate of the kinase in vitro. Consistent with the in vitro results, the Tat protein of HIV-2 interacts with a cellular kinase in HIV-2 Tat-transfected cells and is phosphorylated in vivo. These results suggest that a cellular serine/threonine kinase may act as a mediator of Tat function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249283     DOI: 10.1006/viro.1993.1634

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

Review 2.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Transcriptional activation by artificial recruitment in mammalian cells.

Authors:  J Nevado; L Gaudreau; M Adam; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

5.  Tat-SF1 protein associates with RAP30 and human SPT5 proteins.

Authors:  J B Kim; Y Yamaguchi; T Wada; H Handa; P A Sharp
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 6.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

7.  Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.

Authors:  Q Zhou; D Chen; E Pierstorff; K Luo
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

8.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.

Authors:  Beatrix Meltzer; Deemah Dabbagh; Jia Guo; Fatah Kashanchi; Mudit Tyagi; Yuntao Wu
Journal:  Virology       Date:  2018-03-15       Impact factor: 3.616

10.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.